Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

JAMA

Volumn 281, Issue 7, 1999, Pages 650-655

  Maron, Barry J ^a,b   Casey, Susan A ^a   Poliac, Liviu C ^a   Gohman, Thomas E ^a   Almquist, Adrian K ^a   Aeppli, Dorothee M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; VERAPAMIL; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; SYMPTOMATOLOGY; UNITED STATES;

EID: 0033577053     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.7.650     Document Type: Article

References (31)

1. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127-133.
2. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-1692.
3. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
4. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation. 1998; 98:1460-1471.
5. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation. 1968; 37:759-788.
6. Shah PM, Adelman AG, Wigle ED, et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res. 1974;35(suppl 2): 179-195.
7. Swan DA, Bell B, Oakley C, Goodwin J. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 1971;33:671-685.
8. Adelman AG, Wigle ED, Ranganathan N, et al. The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 hemodynamically proved cases. Ann Intern Med. 1972;77: 515-525.
9. Hardarson T, de la Calzada CS, Curiel R, Goodwin JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973;2:1462-1467.
10. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child. 1984;59:971-975.
11. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis of hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532-538.
12. Fiddler GI, Tajik AJ, Weidman WH, et al. Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol. 1978;42:793-799.
13. Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE. Asymmetric septal hypertrophy in childhood. Circulation. 1976;53:9-18.
14. Maron BJ, Cecchi F, McKenna WJ. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J. 1994; 72(suppl):S13-S18.
15. Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy. Eur Heart J. 1997;18:1249-1256.
16. Knight C, Kurbaan AS, Seggewiss H, et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997;95:2075-2081.
17. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749-755.
18. Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ. Prognosis in hypertrophic cardiomyopathy: a retrospective study. Am J Cardiol. 1993;72:939-943.
19. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995; 26:1529-1536.
20. Shapiro LM, Zezulka A. Hypertrophic cardiomyopathy: a common disease with a good prognosis. Br Heart J. 1983:50:530-533.
21. Cannan CR, Reeder GS, Bailey KR, Melton LJ III, Gersh BJ. Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation. 1995;92:2488-2495.
22. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol. 1990:16:321-826.
23. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-1708.
24. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992; 19:91-99.
25. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. New York, NY: John Wiley & Sons Inc; 1980.
26. Vital Statistics of the United States, Volume II: Mortality: Part A, 1992. Washington, DC: Dept of Health and Human Services; 1992:7. Section 1, tables 1-4.
27. Minnesota Health Statistics. Minneapolis: Minnesota Dept of Health; 1992:29, 50. Tables 29 and 50.
28. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1987;60:123-129.
29. Morrow AG, Reitz BA, Epstein SE, et al. Operative treatment in hypertrophic subaortic stenosis: techniques, and the results of pre and post-operative assessments in 83 patients. Circulation. 1975;52: 88-102.
30. Maki S, Ikeda H, Muro A, et al. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:774-778.
31. Sherrid MV, Pearle G, Gunsburg DZ. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation. 1998;97: 41-47.